Page last updated: 2024-09-04

harmalol hydrochloride and dihydroergocristine monomesylate

harmalol hydrochloride has been researched along with dihydroergocristine monomesylate in 1 studies

Compound Research Comparison

Studies
(harmalol hydrochloride)
Trials
(harmalol hydrochloride)
Recent Studies (post-2010)
(harmalol hydrochloride)
Studies
(dihydroergocristine monomesylate)
Trials
(dihydroergocristine monomesylate)
Recent Studies (post-2010) (dihydroergocristine monomesylate)
7041304

Protein Interaction Comparison

ProteinTaxonomyharmalol hydrochloride (IC50)dihydroergocristine monomesylate (IC50)
5-hydroxytryptamine receptor 4Cavia porcellus (domestic guinea pig)0.239
Cytochrome P450 3A4Homo sapiens (human)3
Alpha-2A adrenergic receptorHomo sapiens (human)0.002
Cytochrome P450 2C9 Homo sapiens (human)3
Beta-3 adrenergic receptorHomo sapiens (human)3.308
D(2) dopamine receptorHomo sapiens (human)0.0015
Alpha-2B adrenergic receptorHomo sapiens (human)0.0079
Alpha-2C adrenergic receptorHomo sapiens (human)0.0087
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)0.0007
D(1A) dopamine receptorHomo sapiens (human)1.179
Alpha-1D adrenergic receptorHomo sapiens (human)0.0074
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.015
5-hydroxytryptamine receptor 2CHomo sapiens (human)0.239
5-hydroxytryptamine receptor 1BRattus norvegicus (Norway rat)0.0007
Cytochrome P450 2C19Homo sapiens (human)3
Mu-type opioid receptorHomo sapiens (human)0.85
D(3) dopamine receptorHomo sapiens (human)0.0023
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.0066
5-hydroxytryptamine receptor 6Homo sapiens (human)0.042

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1

Other Studies

1 other study(ies) available for harmalol hydrochloride and dihydroergocristine monomesylate

ArticleYear
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012